Le Lézard
Classified in: Health, Business
Subject: FDA

Water Street's Partnership with Leading Medical Products Company Leads to FDA Approval of the First and Only Ready-to-Use Insulin for IV Infusion


CHICAGO, July 22, 2019 /PRNewswire/ -- Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that its development partnership with a leading medical products company has resulted in the U.S. Food and Drug Administration (FDA) approval of Insulin Human in 0.9% Sodium Chloride Injection (Insulin Human). It is the first and only ready-to-use insulin for IV infusion.

Water Street Healthcare Logo (PRNewsfoto/Water Street Healthcare Partners)

The new presentation of Insulin Human features an extended shelf life of 30 days at room temperature (77 degrees Fahrenheit /25 degrees Celsius) or 24 months if refrigerated (36 ? 46 degrees Fahrenheit/2-8 degrees Celsius) in the original carton to protect from light. The product is provided in a standardized concentration of 100 units/100 mL in a flexible plastic container.

The approval of Insulin Human marks the eighth drug product successfully developed by Water Street's company, Celerity Pharmaceuticals, LLC. Celerity funded, developed, and led the approval process of Insulin Human. After gaining FDA approval, Celerity transferred ownership of the product to its medical products company partner.

"We're honored to be part of successfully developing this innovative presentation of insulin to advance our partner's goal of introducing medicines in new presentations that help promote clinician efficiency and advance patient care," said Dan Robins, Ph.D., president, Celerity. 

About Water Street
Water Street is a strategic investor focused exclusively on health care. The firm has a strong record of building market-leading companies across key growth sectors in health care. It has worked with some of the world's leading health care companies on its investments including Humana, Johnson & Johnson, Medtronic, and Walgreen Co. Water Street's team is comprised of industry executives and investment professionals with decades of experience investing in and operating global health care businesses. The firm is headquartered in Chicago. For more information about Water Street, visit waterstreet.com.

SOURCE Water Street Healthcare Partners


These press releases may also interest you

at 09:47
Healthfirst, New York's largest not-for-profit health insurer,i has launched the Healthfirst NY Mobile App, an iOS-compatible mobile app created to let Healthfirst's 1.5 million members keep access to healthcare close at hand. Healthfirst members...

at 09:45
The "Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering. This clinical trial report provides an overview of the Coronavirus Disease 2019 (COVID-19) Clinical...

at 09:38
MagicMed Industries Inc. ("MagicMed" or "the Company") today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) covering composition of matter, drug formulation and process of...

at 09:37
The Lawrence J. Ellison Institute for Transformative Medicine of USC ("Ellison Institute") and Oracle reveal a promising two-step technique to train a high-confidence predictive algorithm for enhanced cancer diagnostics. The study uses novel tissue...

at 09:35
Trueblue is making the digital working model of pharmaceutical and life sciences companies more accessible. Trueblue announces the integration of its Artificial Intelligence Relationship Management (AiRM) with Microsoft Dynamics 365 and Power...

at 09:35
A new clinical trial conducted by the Canadian Cancer Society-funded Canadian Cancer Trials Group (CCTG) is the first in the world to test an immune-stimulating treatment to reduce symptoms and prevent severe cases of COVID-19 and other serious...



News published on 22 july 2019 at 09:45 and distributed by: